The market for Celebrex, a non-steroidal anti-inflammatory drug (NSAID), is part of the broader drugs business. The drug is widely used to treat various conditions such as arthritis, osteoarthritis, and benign prostatic hyperplasia.
Celebrex is a prescription Celebrex medication specifically designed to relieve pain and inflammation by inhibiting the production of prostaglandins in the body. This action helps to reduce the workload on the heart and other cardiovascular systems, thereby reducing the risk of heart-related issues and death associated with arthritis.
The global Celebrex market has been growing at a CAGR of 5.2% from a previous report. This significant growth is driven by the high prevalence of the conditions being treated, particularly arthritis. As of 2023, there are more than 26,000 prescriptions for Celebrex for the treatment of arthritis. This growth is expected to continue in coming years, with a market size of 62.6% CAGR of companies with sales of approximately USD 9.2 billion in 2025.
The estimated market size for the next 5 to 10 years is unlikely to be much better. The market's recovery is likely to be poor, with estimates suggesting that it will reach a value of USD 9.8 billion in 2029. The market's size is also led by the global manufacturer and distributor Beiersd SOFTWARE, which has a revenue of USD 63.5 billion and a sales of USD 8.5 billion.
Several factors are driving the growth of the Celebrex market:
Dr. Reddy's, a major players in the Celebrex market, is the major players. They include:
Teva Pharmaceutical Industries Ltd. (Vietnam) - - A major player in the generic Celebrex market. They are the world's largest generic manufacturer of Celebrex and their generic version, Beiersd, is one of the leading generics manufacturers. They are the world's largest manufacturers of generic Celebrex, with sales of USD 58.2 billion and are the world's leading players in the medical products segment. Their product portfolio includes branded and generic Celebrex, as well as their medical products, pain relief and anti-inflammatory medications.
Zenid Pharmaceuticals - - A significant player in the Celebrex market. They are the world's largest company by revenue and their own branded company.
CELEBREX 200MG CAPSULE contains Celecoxib which belongs to group of medicines called Non-steroidal anti-inflammatory drugs. CELEBREX 200MG CAPSULE is used in adults to manage osteoarthritis (degenerative joint disease), rheumatoid arthritis (inflammatory disease of joints), ankylosing spondylitis (chronic back pain), acute pain and primary dysmenorrhea (menstrual cramps).
CELEBREX 200MG CAPSULE is also used to manage juvenile rheumatoid arthritis (in children aged 2 years and above).
CELEBREX 200MG CAPSULE is not recommended for use in patients allergic to Celecoxib, sulfonamides, aspirin and/or other NSAIDs. It is also not recommended for use in patients with/had a history of an ulcer in stomach/intestines, bleeding in stomach/intestines, blood circulation problems (such as peripheral arterial disease), red itchy welts, inflammatory disease of the intestines (such as ulcerative colitis/Crohn’s disease).
The medicine is also not indicted for use in patients suffering from lung problems (such as asthma), heart diseases (such as heart failure, recent heart attack, heart block), severe liver disease (such as advanced hepatic insufficiency) and/or kidney disease (such as advanced renal insufficiency).
Before taking CELEBREX 200MG CAPSULE, inform your doctor if you have diabetes, raised blood pressure, increased cholesterol, signs of fluid retention (such as swollen ankles and feet) and/or hyperkalemia (increased potassium level in blood).
CELEBREX 200MG CAPSULE is not recommended for use in pregnant and breast-feeding women.
CELEBREX 200MG CAPSULE should be used with caution in children and adolescents (aged 2 to 17 years) to manage only juvenile rheumatoid arthritis and is advised to be used with caution in elderly patients (aged 65 years/above) after consulting the doctor.
The most common side effects of taking CELEBREX 200MG CAPSULE are high blood pressure, shortness of breath, sore throat, cough, headache, nausea and dizziness. Consult your doctor if any of these symptoms worsen.
The brand and generic Celecoxib is ibuprilenafil. The other medications (Celebrex) they contain include naproxen, diclofenac, indomethacin, cisapride, barbiturate, disopyramide, disopyron and amoxican. Consult your doctor if any of these Medicine or medicine brand side effects persist or become bothersome.What is Celecoxib?Celebrex is an FDA approved medicine used to manage breast blood vessels and tissue inflammation. This medication works by blocking the ulcer-causing enzyme lactoferrin, preventing the production of stomach acid. This lowers the risk of gastrointestinal side effects in people who have a sensitivity to sunlight. This medicine is not recommended for use in patients allergic to Celecoxib, sulfonamides, aspirin, or other NSAIDs. It is also not recommended for use in patients suffering from an ulcer in stomach/intestination, bleeding in stomach/intestination and/or in patients with rheumatoid arthritis.
What Strengths and Rallyings are Celecoxib?CELEBREX 200MG CAPSULE contains Celecoxib which is a proven COX-1 (celecoxib) inhibitor. This medicine belongs to a group of drugs called Non-steroidal anti-inflammatory drugs (NSAIDs) which works by stopping the production of prostaglandins which cause pain, swelling and inflammation in the body. This reduces pain and inflammation and enhances relief from swelling and pain.
The active ingredient of each capsule is a non-steroidal anti-inflammatory drug different from tablet to capsule. The active ingredient of each CELEBREX 200MG CAPSULE is different.
In clinical studies, people who took Celecoxib capsule for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, an enteritis and an inflammation of the intestines also found higher success rates in managing children under 2 years of age with juvenile rheumatoid arthritis than those who took a tablet.
Pfizer, Inc. (NYSE: PFE)
With a focus on discovering and marketing the most effective and most profitable medicines, the U. S. Food and Drug Administration has been working to educate the public about the risks and benefits of celecoxib, the active ingredient in the blockbuster arthritis medicine Celebrex. As part of the FDA’s effort to make it easier for physicians and patients to use this new drug, Pfizer is informing the public of the potential for serious side effects associated with celecoxib, including gastrointestinal problems, bone density loss, and death. The FDA also wants to alert the public that there is not enough evidence that celecoxib can increase the risk of heart attacks or strokes. In addition to warning people of the possible risks, the FDA is also encouraging healthcare providers to monitor for signs and symptoms of low bone mineral density and for any new problems that may occur. Additionally, the FDA is encouraging all physicians, nurses, and other health care professionals to report any new or worsening symptoms, including bone loss, to their primary care physician, if any.
Celecoxib is the only new drug that has been approved by the FDA in the United States for the treatment of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, psoriatic arthritis, and acute pain. It is also the only new drug in the same category to use in children and adults with a normal height and weight. However, many other new drugs are currently under investigation for the same problem.
Celecoxib has been the subject of intense research and development since the launch of the drug in January 2000. The Food and Drug Administration has identified several risks that patients and medical professionals should be aware of.
FDA-sponsored research has identified an increased risk of stroke, heart attack, or death for patients taking celecoxib. Some of these patients may also have a reduced bone mineral density, while others may have an increased risk of fractures and an increased risk of death.
Celecoxib has been shown to have other important health benefits, including the prevention of the development of cancer and certain types of cancers.
Although the FDA has not approved a new drug for the treatment of osteoarthritis, there is still strong scientific evidence that the drug can help prevent arthritis in patients who have already suffered a hip or knee surgery.
The FDA is also promoting the use of celecoxib for pain relief in adults and children who have had a recent hip or knee surgery.
The FDA is encouraging parents to monitor for any signs and symptoms of low bone density, especially in patients who have a normal height and weight. Patients should also be aware that the risk of osteoporosis increases with age.
The FDA is also encouraging all physicians, nurses, and other health care professionals to report any new or worsening symptoms of low bone density, including osteoporosis, to their primary care physician, if any.
For more information, please visit.
PfizerCopyright 2019 Pfizer Inc. All rights reserved. This information is for educational and educational purposes only. It is not intended to replace the advice of a physician. Talk to your physician or pharmacist for more information about celecoxib and other medical treatment options for osteoarthritis and rheumatoid arthritis.
This information is for educational purposes only.
Pfizer is a registered trademark of AstraZeneca PLC. AstraZeneca PLC is a subsidiary of P. O. Box 52027, Durham, NC 27737-2027. All other trademarks are the property of their respective owners.
Pfizer Inc. is a leading healthcare business with a global headquarters in both North America and Europe.
Celebrex and Ibuprofen are two non-steroidal anti-inflammatory drugs (NSAIDs), commonly used for pain relief, primarily in managing ulcers and certain types of arthritis. Both medications contain the active ingredient celecoxib, which has been clinically proven to reduce pain and inflammation in the stomach, small intestine, and kidneys.
Both drugs are commonly used to relieve pain and inflammation in conditions such as arthritis, menstrual cramps, and other musculoskeletal conditions. However, they have different side effects, and there are ways to manage them effectively.
Both NSAIDs cause side effects such as gastrointestinal discomfort, heartburn, and joint pain. However, they have different types of side effects, and there are ways to manage them effectively.
Stade de France Pharmacy